CUSIP 00887A204COM NEWRNTXQ4 2025
13 filings · latest Feb 13, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Voss Capital, LP | 4.24M | $4.92M |
| 2 | Bios Capital Management, LP | 1.69M | $1.96M |
| 3 | Vanguard Group Inc | 1.17M | $1.35M |
| 4 | University Of Texas/Texas Am Investment Management Co | 511.6K | $593.5K |
| 5 | Prosight Management, LP | 442.6K | $513.4K |
| 6 | Cable Car Capital, LP | 420.0K | $487.2K |
| 7 | Geode Capital Management, LLC | 284.6K | $330.2K |
| 8 | Texas Capital Bank Wealth Management Services Inc | 262.1K | $304.1K |
| 4 | May 14, 2025 | Voss Value Master Fund, LP | 13G | 5.6% | 1.28M | SEC |
| 5 | Nov 5, 2024 | University Of Texas/Texas Am Investment Management Co | 13G/A | 4.4% | 960.7K | SEC |
| 6 | Apr 16, 2024 | Satter Muneer A | 13D/A | 4.9% | 830.5K | SEC |
| 7 | Mar 5, 2024 | University Of Texas/Texas Am Investment Managment Co | 13G | 6.2% | 1.81M | SEC |
| 8 | Mar 5, 2024 | Satter Muneer A | 13D/A | 5.9% | 1.02M | SEC |
| 9 | Feb 14, 2024 | Biotechnology Value Fund L P | 13G/A | — | — | SEC |
| 10 | Feb 5, 2024 | Kapnick Scott | 13G/A | — | — | SEC |
See the full Schedule 13D/13G history for Rein Therapeutics Inc.
Unlock full history| 9 |
| Sigma Planning Corp |
| 247.3K |
| $298.6K |
| 10 | Gagnon Securities LLC | 240.2K | $278.7K |